Skip to content
Review Open access

Role of non-pharmacological cognition building techniques in delayed progression of Alzheimer's disease: A matter of blood-brain barrier dysfunction

2026 · Scripta Medica · Vol 57, pp. 863-878 · 0 citations · 115 references

TL;DR

The aim of the current study was to improve memory and other aspects of cognitive functioning in individuals with early-stage dementia and Alzheimer's disease.

Abstract

Cognitive rehabilitation treatments for Alzheimer's disease and early-stage dementia are increasingly accessible to older adults and aim to slow the progressive decline in functional performance and cognitive abilities associated with ageing. Alzheimer's disease may involve disruption of affected brain systems, impaired self-awareness, general difficulties performing daily activities, reduced motivation, despondency and lethargy. These symptoms may result directly from the disease or may be associated with depressive episodes. Cognitive rehabilitation exercise programmes are labour-intensive and rely heavily on repetition to reinforce memory, particularly because patients must repeatedly confront their memory impairments and the consequences associated with them. Therefore, patients must be adequately committed and motivated both to begin a rehabilitation programme and to remain engaged throughout the intervention. Achieving an appropriate treatment dosage is also essential for cognitive rehabilitation techniques to be effective. This review investigated the efficacy and effects of cognitive training and cognitive rehabilitation interventions in patients in the early stages of Alzheimer's disease or vascular dementia. The aim of the current study was to improve memory and other aspects of cognitive functioning in individuals with early-stage dementia and Alzheimer's disease.

Read PDF

Similar papers

Conference Open access Oct 2026

Effectiveness of Non-Pharmacological Interventions in Alzheimer’s Disease

Alzheimer's disease is an irreversible progressive neurological disorder that progressively destroys key cognitive abilities ultimately impairing a person’s ability to conduct simple tasks. While Food and Drug Administration approved medication exists for patients with Alzheimer's, there is currently no cure to reverse...

Arshia Deshpande · 0 citations
Open access 2026

Impact of Nursing Intervention on Memory Performance Among Patients with Alzheimer's Disease in Selected Hospitals

Introduction: Dementia, cognitive decline, and impaired ability to carry out daily tasks are hallmarks of Alzheimer's disease (AD), a neurological disorder that worsens over time. Methodology: The researchers used a quasi-experimental approach based on a before-and-after comparison of one group with sixty patients diag...

Durga Devi M, J. P. · 0 citations
Review Open access Oct 2026

Cognitive training for mild neurocognitive disorder: a review of recent evidence and emerging directions.

PURPOSE OF REVIEW Older adults with mild neurocognitive disorder (MND), also referred to as mild cognitive impairment, exhibit measurable cognitive deficits while maintaining a relatively preserved autonomy, but are at increased dementia risk. Because learning capacity and neuroplasticity remain substantial during this...

S. Belleville, P. Emhjellen, Stella Ruddy · 0 citations
Review Open access Oct 2026

Mind-Motor Mat Training as an Early Adjunct to Antihypertensive Therapy for Cognitive Preservation.

Hypertension affects over 1.28 billion adults globally and remains a critical contributor to cardiovascular complications, mortality, and cognitive decline. Its prevalence approaches 25% in Pakistan, with many cases remaining undiagnosed or uncontrolled. Chronic elevation in blood pressure damages cerebral vasculature,...

S. Bashir, Arzoo Bashir, M. Baig · 0 citations
Review Oct 2026

From pathogenesis to non-medical therapy: A review of exploring sensory and multi-sensory stimulation as a non-invasive treatment approach for Alzheimer's disease.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, marked by the accumulation of amyloid-beta plaques, tau pathology, and synaptic dysfunction, ultimately leading to memory loss, cognitive decline, neuropsychiatric symptoms and neuronal degeneration that impairs daily functioning. Despite the availab...

Yu-Jun Zhu, Zahra Jafari, Bryan E. Kolb et al. · 0 citations
Review Open access Oct 2026

Brain–Computer Interfaces for Cognitive Rehabilitation: A Narrative Review

Cognitive diseases/disorders are a major cause of disability affecting millions of people worldwide due to pathologies or conditions such as Alzheimer’s disease, Parkinson’s disease, vascular cognitive impairment, and attention deficit/hyperactivity disorder. The effects of these diseases/disorders can range from subje...

Jessica Cantillo-Negrete, M. E. Rodríguez-García, Paul Carrillo-Mora et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.